Form 4: Avanos Medical Executive John Joseph Hurley Reports Acquisition of Restricted Share Units

Principal Accounting Officer John Joseph Hurley reports the acquisition of 3,001 restricted share units in Avanos Medical, Inc.

Summary

• On September 5, 2024, John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc., acquired 3,001 time-based restricted share units (TRSUs).
• These TRSUs were awarded under the Issuer's 2021 Long Term Incentive Plan, as amended.
• The TRSUs will vest in three equal installments: 1/3 on September 5, 2025, 1/3 on September 5, 2026, and 1/3 on September 5, 2027.
• Each TRSU is equivalent to one share of Avanos Medical's common stock.
• Following the transaction, Hurley directly owns 9,646 shares of common stock.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of restricted share units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The vesting schedule of the restricted share units suggests an expectation of continued employment and contribution from the executive over the next three years.

Industry Context

The granting of restricted stock units is a common practice in executive compensation to align management's interests with those of shareholders and incentivize long-term value creation.

Stakeholder Impact

• The granting of restricted stock units aligns management's interests with those of shareholders, potentially leading to better long-term performance.

Key Dates